TECHNIQUE

New tools for transcriptome-wide mapping of m6A

N6-methyladenosine (m6A) is the most prevalent covalent modification of mammalian mRNA and is involved in regulating post-transcriptional gene expression. Despite methodological advances, it remains challenging to directly map all m6A sites in the transcriptome. Now, Nature Chemical Biology reports two new methods that enable transcriptome-wide mapping of m6A independently of sequence context.

Existing methods have provided invaluable information about the m6A landscape but each has limitations. Antibody-based m6A-seq (also termed MeRIP-seq) has a low resolution of 100–200 nucleotides. Other methods indirectly infer the positions of modified adenosines from their proximity to RNA–antibody crosslinking sites (in crosslinking and immunoprecipitation (CLIP)-based approaches) or enzymatically modified sites (in deamination adjacent to RNA modification targets (DART)-seq). Approaches based on m6A-sensitive endoribonucleases (such as m6A-REF-seq or MAZTER-seq) detect only the ~16–25% of total m6A sites that fall within their recognition motif.

Credit: Paulus Rusyanto/EyeEm/Alamy

Detection of m6A is challenging because the N6-methyl group is largely unreactive and therefore difficult to chemically label. Additionally, m6A does not cause nucleotide mis-incorporation or termination during reverse transcription (RT), which precludes the use of mutation- or truncation-based sequencing readouts.

To address these issues, Shu et al. developed m6A-label-seq, a single-nucleotide resolution, transcriptome-wide approach based on metabolic labelling. Normally, m6A methylation enzymes transfer a methyl group from S-adenosyl methionine (SAM) to the N6 position of target adenosines. However, in cells cultured with a SAM analogue, Se-allyl-l-selenohomocysteine (SeAM), m6A sites are instead metabolized to N6-allyladenosine (a6A). Chemically induced cyclization of a6A can lead to mis-incorporations during RT, enabling detection of modified adenosines as A-to-T/C/G mutations in sequencing data.

In proof-of-concept experiments, m6A-label-seq detected a few thousand modified sites in each of three different cell types (human HeLa and HEK293T and mouse H2.35), a subset of which were validated by an orthogonal approach. Comparisons with published data for other single-base resolution techniques (DART-seq, m6A-REF-seq and miCLIP) in HEK293T cells indicated that m6A-label-seq is better at detecting clustered m6A sites. The authors suggest that the superior performance of m6A-label-seq reflects the limitations of indirect and sequence-dependent approaches.

Wang et al. based the second method, m6A-SEAL, on the ability of FTO RNA demethylase to convert m6A into a reactive intermediate, N6-hydroxymethyladenosine (hm6A). Subsequent treatment of hm6A with dithiothreitol (DTT) generated N6-dithiolsitolmethyladenosine (dm6A), which has a free sulfhydryl group that can be functionally tagged with biotin for streptavidin-based affinity purification followed by sequencing.

The authors show that m6A-SEAL specifically detects converted m6A and is highly sensitive — it can be performed on as little as 500 ng of polyA+ RNA. Comparisons of false-positive rates indicate that it is more reliable than MeRIP-seq, DART-seq, m6A-REF-seq and a number of CLIP-based methods. Although the current version of m6A-SEAL has a low resolution, comparable to that of m6A-seq, the authors hope that single-nucleotide resolution can be achieved by adopting readouts based on terminated or disrupted RT. A notable strength of m6A-SEAL is its flexibility. Optimizing conditions should enable the detection of other RNA modifications, such as hm6A or N6,2ʹ-O-dimethyladenosine at the cap +1 position (cap m6Am). Moreover, the sulfhydryl group can be tagged with different functional groups for different applications, such as fluorophores for imaging.

“m6A-label-seq and m6A-SEAL represent complementary, orthogonal techniques”

m6A-label-seq and m6A-SEAL represent complementary, orthogonal techniques that, together with existing approaches, will facilitate a fuller understanding of the distribution and biological roles of m6A RNA modification.

References

Original articles

  1. Shu, X. et al. A metabolic labeling method detects m6A transcriptome-wide at single base resolution. Nat. Chem. Biol. https://doi.org/10.1038/s41589-020-0526-9 (2020)

    Article  PubMed  Google Scholar 

  2. Wang, Y. et al. Antibody-free enzyme-assisted chemical approach for detection of N 6-methyladenosine. Nat. Chem. Biol. https://doi.org/10.1038/s41589-020-0525-x (2020)

    Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Dorothy Clyde.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Clyde, D. New tools for transcriptome-wide mapping of m6A. Nat Rev Genet 21, 387 (2020). https://doi.org/10.1038/s41576-020-0248-6

Download citation

Search

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing